Toxicology Research Today is a free monthly online journal that collates and summarizes the latest research about Toxicology, including details on forensic toxicology, carcinogenicity, assays.

Volume 2 (2006), Issue 1 (January)

1. Zebrafish in functional genomics and aquatic biomedicine.
   Trends Biotechnol, 24(1): 15-21. [Abstract] [Full-text]
2. Assessment of pepper spray product potency in Asian and Caucasian forearm skin using transepidermal water loss, skin temperature and reflectance colorimetry.
   J Appl Toxicol, 26(1): 88-97. [Abstract] [Full-text]
3. A review of evidence leading to the prediction that 1,4-butanediol is not a carcinogen.
   J Appl Toxicol, 26(1): 72-80. [Abstract] [Full-text]
4. Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640.
   Ann N Y Acad Sci, 1058: 215-34. [Abstract] [Full-text]
5. The speciation of metals in mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment(1).
   J Toxicol Environ Health B Crit Rev, 9(1): 63-85. [Abstract] [Full-text]
6. Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS.
   J Proteome Res, 5(1): 98-104. [Abstract] [Full-text]
7. Environmental health information resources: healthy environments for healthy women and children.
   J Midwifery Womens Health, 51(1): 35-8. [Abstract] [Full-text]
8. Obtaining pediatric indications for new anti-epileptic drugs: how and when.
   Epilepsy Res, 68(1): 38-42. [Abstract] [Full-text]
9. Toxicogenomic analysis methods for predictive toxicology.
   J Pharmacol Toxicol Methods, 53(1): 31-7. [Abstract] [Full-text]
10. QSPR models for polychlorinated biphenyls: n-Octanol/water partition coefficient.
    Bioorg Med Chem, 14(4): 1021-8. [Abstract] [Full-text]
11. Stable isotopes, mass spectrometry, and molecular fluxes: applications to toxicology.
    J Pharmacol Toxicol Methods, 53(1): 75-85. [Abstract] [Full-text]
12. Systems-ADME/Tox: resources and network approaches.
    J Pharmacol Toxicol Methods, 53(1): 38-66. [Abstract] [Full-text]
13. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
    J Pharmacol Toxicol Methods, 53(1): 11-9. [Abstract] [Full-text]
14. A shared response model for clustered binary data in developmental toxicity studies.
    Biometrics, 61(4): 1076-84. [Abstract] [Full-text]
15. Development and regulation of monoclonal antibody products: challenges and opportunities.
    Cancer Metastasis Rev, 24(4): 569-84. [Abstract] [Full-text]
16. Clinical toxicology: clinical science to public health.
    Clin Exp Pharmacol Physiol, 32(11): 995-8. [Abstract] [Full-text]
17. Toxicogenomics in risk assessment: applications and needs.
    Toxicol Sci, 89(2): 352-60. [Abstract] [Full-text]
18. Voltammetric behavior of nitrazepam and its determination in serum using liquid chromatography with redox mode dual-electrode detection.
    Anal Chem, 78(2): 416-23. [Abstract] [Full-text]
19. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies.
    Anal Chem, 78(2): 363-71. [Abstract] [Full-text]
20. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
    Mol Ther, 13(2): 347-56. [Abstract] [Full-text]
21. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.
    Trends Pharmacol Sci, 27(1): 10-6. [Abstract] [Full-text]
22. EMTs' attitudes' toward death before and after a death education program.
    Prehosp Emerg Care, 10(1): 89-95. [Abstract] [Full-text]
23. Classification ensembles for unbalanced class sizes in predictive toxicology.
    SAR QSAR Environ Res, 16(6): 517-29. [Abstract] [Full-text]
24. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug.
    Prostate, 66(4): 358-68. [Abstract] [Full-text]
25. Principles and practices of health risk assessment under current EU regulations.
    Regul Toxicol Pharmacol, 44(1): 14-23. [Abstract] [Full-text]
26. Determination of morphine in the plasma of addicts in using Zeolite Y extraction following high-performance liquid chromatography.
    Clin Chim Acta, 364(1): 235-8. [Abstract] [Full-text]
27. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
    Mol Carcinog, 45(2): 118-25. [Abstract] [Full-text]
28. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack.
    Resuscitation, 68(2): 193-202. [Abstract] [Full-text]
29. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.
    Cardiovasc Res, 69(3): 677-87. [Abstract] [Full-text]
30. In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug.
    Invest New Drugs, 24(1): 3-14. [Abstract] [Full-text]
31. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
    Addiction, 101(2): 275-81. [Abstract] [Full-text]

© 2005-2008 Toxicology Research Today. All Rights Reserved.